Mitchell D Schnall Selected Research

Mitchell D Schnall Research Topics

Disease

28	Neoplasms (Cancer) 12/2020 - 03/2002
14	Breast Neoplasms (Breast Cancer) 06/2018 - 03/2003
3	Glioma (Gliomas) 01/2020 - 01/2017
2	Multiple Sclerosis 01/2022 - 09/2019
2	Pathologic Complete Response 06/2018 - 04/2016
2	Carcinoma (Carcinomatosis) 01/2017 - 12/2002
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2017 - 01/2006
2	Fibroadenoma 07/2014 - 07/2002
2	Renal Cell Carcinoma (Grawitz Tumor) 04/2008 - 01/2007
2	Carcinogenesis 01/2007 - 12/2002
2	Prostatic Neoplasms (Prostate Cancer) 06/2004 - 01/2003
1	Stable Angina 12/2020
1	Pathologic Constriction (Stenosis) 12/2020
1	Death (Near-Death Experience) 12/2020
1	Myocardial Infarction 12/2020
1	Residual Neoplasm 04/2016
1	Lymphoma (Lymphomas) 01/2016
1	Fibrosis (Cirrhosis) 08/2015
1	Necrosis 08/2015
1	Triple Negative Breast Neoplasms 07/2014
1	Carcinoma in Situ 01/2007
1	Lymphadenopathy 04/2004
1	Margins of Excision 01/2003
1	Cysts 03/2002

Drug/Important Bio-Agent (IBA)

5	GadoliniumIBA 01/2022 - 05/2004
5	Contrast MediaIBA 01/2017 - 03/2003
5	Hemoglobins (Hemoglobin)IBA 05/2015 - 07/2002
3	Biomarkers (Surrogate Marker)IBA 12/2020 - 05/2015
2	Biological ProductsIBA 01/2020 - 05/2013
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2020 - 01/2016
2	Sweetening Agents (Sweeteners)IBA 01/2019 - 01/2017
2	Protons (Proton)IBA 01/2019 - 01/2016
2	Hormones (Hormone)IBA 04/2016 - 06/2004
2	ErbB Receptors (EGF Receptor)IBA 04/2016 - 07/2014
1	omega-Chloroacetophenone (Mace)IBA 12/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Glutamine (L-Glutamine)FDA Link 01/2020
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2020
1	Acetates (Acetic Acid Esters)FDA Link 01/2020
1	Hydroxyl RadicalIBA 01/2019
1	maltitolIBA 01/2019
1	Sugar AlcoholsIBA 01/2019
1	SolutionsIBA 01/2017
1	trichlorosucrose (sucralose)IBA 01/2017
1	Pentetic Acid (DTPA)FDA LinkGeneric 01/2017
1	Pyruvic Acid (Pyruvate)IBA 01/2016
1	A 19IBA 08/2015
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 08/2015
1	Oxygen (Dioxygen)IBA 05/2015
1	Complement System Proteins (Complement)IBA 05/2015
1	Estrogen ReceptorsIBA 07/2014
1	taxaneIBA 06/2012
1	AnthracyclinesIBA 06/2012
1	N 30IBA 12/2008
1	Sorafenib (BAY 43-9006)FDA Link 04/2008
1	Angiogenesis InhibitorsIBA 04/2008
1	Pharmaceutical PreparationsIBA 01/2007
1	Tumor Biomarkers (Tumor Markers)IBA 08/2006
1	CytokinesIBA 08/2006
1	Prostate-Specific Antigen (Semenogelase)IBA 06/2004
1	P-2 (P 2)IBA 05/2004
1	AndrogensIBA 01/2003
1	Doxycycline (Periostat)FDA LinkGeneric 12/2002
1	Tetracycline (Achromycin)FDA LinkGeneric 12/2002
1	ElementsIBA 03/2002
1	Vitamin E FDA LinkGeneric 03/2002

Therapy/Procedure

7	Therapeutics 12/2020 - 01/2003
6	Neoadjuvant Therapy 06/2018 - 06/2012
3	Segmental Mastectomy (Lumpectomy) 01/2017 - 02/2004
3	Radiotherapy 01/2017 - 01/2003
2	Aftercare (After-Treatment) 12/2014 - 04/2004
2	Prophylactic Mastectomy 10/2014 - 03/2003
1	Mastectomy (Mammectomy) 01/2006
1	Prostatectomy (Retropubic Prostatectomy) 01/2003